ArticleAnnals of internal medicine2017
Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
Lorraine L LipscombePubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it
ArticleAnnals of internal medicine2017
Lorraine L LipscombePubMed ↗Publisher ↗
No numbers read from the abstract.